After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
The Scientist
Most Recent
Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.
Women have come a long way, but roadblocks remain
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
Patient safety is paramount in regulating new stem cell treatments.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
People carrying a certain gene variant that dictates fresh underarms are less likely to wear antiperspirant.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
